Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$6.52

-0.01 (-0.15%)

07:29
09/15/17
09/15
07:29
09/15/17
07:29

TherapeuticsMD 'countdown has begun' with data submission, says Cantor

Cantor Fitzgerald analyst William Tanner says the "countdown has begun" for TherapeuticsMD's TX-004 now that the company disclosed additional endometrial safety data have been submitted to the FDA. He sees the shares being "range-bound in classic battleground stock fashion" ahead of the FDA's decision, barring provision of any additional information. Tanner has an Overweight rating on TherapeuticsMD with a $33 price target.

  • 25

    Sep

  • 03

    Nov

TXMD TherapeuticsMD
$6.52

-0.01 (-0.15%)

09/05/17
CANT
09/05/17
NO CHANGE
Target $33
CANT
Overweight
FDA should be comforted by article on TherapeuticsMD's TX-004, says Cantor
Cantor Fitzgerald analyst William Tanner notes TherapeuticsMD will host a conference call Wednesday with an author of the National Institutes of Health paper on vaginal estrogen and safety observations from the Women's Health Initiative Observational Study. The analyst believes that while recently published in the journal Menopause, many investors may not be familiar with the findings. Results of the analysis should provide the FDA "with additional comfort" regarding low-dose estrogen safety and support approval of TX-004 without the need for 12-month safety testing beforehand, Tanner tells investors in a research note. He keeps an Overweight rating on TherapeuticsMD with a $33 price target.
09/07/17
JEFF
09/07/17
NO CHANGE
Target $15
JEFF
Buy
Jefferies say key opinion leader supportive of TherapeuticsMD's TX-004
TherapeuticsMD management last night participated in a conference call with Dr. Kaunitz, a co-author of the recently published National Institutes of Health paper on vaginal estrogen and safety observations from the Women's Health Initiative Observational Study, Jefferies analyst Matthew Andrews tells investors in a research note. Kaunitz believes the data reinforce the long-term safety of vaginal estrogen, and does not believe there is a safety signal for elevated endometrial cancers, the analyst adds. Andrews admits that there are limitations with the study. He has a Buy rating on TherapeuticsMD with a $15 price target.
09/08/17
MSCO
09/08/17
INITIATION
Target $6
MSCO
Equal Weight
TherapeuticsMD initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Thomas Smith started TherapeuticsMD with an Equal Weight rating and $6 price target. He believes TX-001HR and TX-004HR are promising products. However, TX-004HR has regulatory uncertainty and he thinks consensus expectations for the product are overly optimistic.
09/13/17
DBAB
09/13/17
NO CHANGE
Target $10
DBAB
Buy
Deutsche Bank positive on TherapeuticsMD's compounding switch potential
Deutsche Bank analyst Esther Rajavelu recently met with two compounding pharmacists to assess their ability and motivation to switch patients to TX-001, TherapeuticsMD's single pill combination for vasomotor symptoms in menopausal women. The analyst remains optimistic over "strong uptake in this patient segment." The company's opportunity from compounded hormone therapies to TX-001 remains underappreciated, Rajavelu tells investors in a research note. The analyst models launch in late 2018 with revenue reaching $1B in five years. Rajavelu reiterates a Buy rating on the shares with a $10 price target.

TODAY'S FREE FLY STORIES

HAL

Halliburton

$53.01

0.65 (1.24%)

06:54
01/22/18
01/22
06:54
01/22/18
06:54
Hot Stocks
Halliburton continues to experience delays in collecting payments in Venezuela »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

JNPR

Juniper

$27.85

0.19 (0.69%)

, AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

06:54
01/22/18
01/22
06:54
01/22/18
06:54
Upgrade
Juniper, Amazon.com rating change  »

Oppenheimer calls Amazon…

JNPR

Juniper

$27.85

0.19 (0.69%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 18

    Mar

HPQ

HP Inc.

$23.70

0.41 (1.76%)

06:54
01/22/18
01/22
06:54
01/22/18
06:54
Recommendations
HP Inc. analyst commentary  »

HP does not see sharp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

GEF

Greif

$60.82

1.13 (1.89%)

06:53
01/22/18
01/22
06:53
01/22/18
06:53
Conference/Events
Greif management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 29

    Mar

VR

Validus

$46.72

0.81 (1.76%)

, AIG

AIG

$61.55

0.02 (0.03%)

06:53
01/22/18
01/22
06:53
01/22/18
06:53
Hot Stocks
AIG to acquire Validus for $5.56B, or $68 per share, in cash »

American International…

VR

Validus

$46.72

0.81 (1.76%)

AIG

AIG

$61.55

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

HAL

Halliburton

$53.01

0.65 (1.24%)

06:52
01/22/18
01/22
06:52
01/22/18
06:52
Hot Stocks
Halliburton CEO: On path to to normalized margins in North America in 2018 »

"Outstanding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VR

Validus

$46.72

0.81 (1.76%)

, AIG

AIG

$61.55

0.02 (0.03%)

06:52
01/22/18
01/22
06:52
01/22/18
06:52
Hot Stocks
Breaking Hot Stocks news story on Validus, AIG »

AIG to acquire Validus…

VR

Validus

$46.72

0.81 (1.76%)

AIG

AIG

$61.55

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

CELG

Celgene

$102.65

0.93 (0.91%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

06:51
01/22/18
01/22
06:51
01/22/18
06:51
Conference/Events
Celgene to host conference call »

Conference call to…

CELG

Celgene

$102.65

0.93 (0.91%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

HAL

Halliburton

$53.01

0.65 (1.24%)

06:50
01/22/18
01/22
06:50
01/22/18
06:50
Earnings
Halliburton reports Q4 adjusted cont ops EPS 53c, consensus 46c »

Reports Q4 revenue $5.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

BOH

Bank of Hawaii

$86.73

0.47 (0.54%)

06:49
01/22/18
01/22
06:49
01/22/18
06:49
Earnings
Bank of Hawaii reports Q4 EPS $1.01, consensus $1.07 »

Reports Q4 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VR

Validus

$46.72

0.81 (1.76%)

06:49
01/22/18
01/22
06:49
01/22/18
06:49
Hot Stocks
Breaking Hot Stocks news story on Validus »

Validus trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

AIG

AIG

$61.55

0.02 (0.03%)

06:49
01/22/18
01/22
06:49
01/22/18
06:49
Hot Stocks
Breaking Hot Stocks news story on AIG »

AIG trading halted, news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

CBU

Community Bank System

$55.39

0.84 (1.54%)

06:48
01/22/18
01/22
06:48
01/22/18
06:48
Hot Stocks
Community Bank System raises quarterly dividend to 34c from 32c per share »

During the fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

BCS

Barclays

$11.14

0.07 (0.63%)

06:48
01/22/18
01/22
06:48
01/22/18
06:48
Periodicals
Tiger Global invests over $1B in Barclays, FT reports »

U.S. hedge fund Tiger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBU

Community Bank System

$55.39

0.84 (1.54%)

06:47
01/22/18
01/22
06:47
01/22/18
06:47
Earnings
Community Bank System reports Q4 adjusted EPS 67c, consensus 71c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

HAWK

Blackhawk

$45.25

0.1 (0.22%)

06:47
01/22/18
01/22
06:47
01/22/18
06:47
Downgrade
Blackhawk rating change  »

Blackhawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLD

TopBuild

$77.28

0.7 (0.91%)

06:46
01/22/18
01/22
06:46
01/22/18
06:46
Hot Stocks
TopBuild acquires Santa Rosa Insulation and Fireproofing, terms not disclosed »

TopBuild has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$44.67

0.1 (0.22%)

06:43
01/22/18
01/22
06:43
01/22/18
06:43
Upgrade
TSMC rating change  »

TSMC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.61

-0.16 (-2.77%)

06:43
01/22/18
01/22
06:43
01/22/18
06:43
Downgrade
Wipro rating change  »

Wipro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.75

-2.25 (-3.75%)

06:41
01/22/18
01/22
06:41
01/22/18
06:41
Downgrade
CBS rating change  »

CBS downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

PANW

Palo Alto Networks

$157.22

-0.6 (-0.38%)

06:40
01/22/18
01/22
06:40
01/22/18
06:40
Downgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

DIS

Disney

$110.59

0.17 (0.15%)

06:40
01/22/18
01/22
06:40
01/22/18
06:40
Recommendations
Disney analyst commentary  »

Disney Q1 seen lower on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

SPX

S&P 500

06:39
01/22/18
01/22
06:39
01/22/18
06:39
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$53.00

0.66 (1.26%)

06:38
01/22/18
01/22
06:38
01/22/18
06:38
Upgrade
Harley-Davidson rating change  »

Wells Fargo upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CRZO

Carrizo Oil & Gas

$22.62

-0.21 (-0.92%)

06:37
01/22/18
01/22
06:37
01/22/18
06:37
Hot Stocks
Carrizo Oil & Gas closes DJ Basin divestiture »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.